Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas13 has drawn broad interest to control gene expression and cell fate at the RNA level in general. Apart from RNA interference mediated by its endonuclease activity, the nuclease-deactivated form of Cas13 further provides a versatile RNA-guided RNA-targeting platform for manipulating kinds of RNA modifications post-transcriptionally. Chemical modifications modulate various aspects of RNA fate, including translation efficiency, alternative splicing, RNA-protein affinity, RNA-RNA interaction, RNA stability and RNA translocation, which ultimately orchestrate cellular biologic activities. This review summarizes the history of the CRISPR-Cas13 system, fundamental components of RNA modifications and the related physiological and pathological functions. We focus on the development of epi-transcriptional editing toolkits based on catalytically inactive Cas13, including RNA Editing for Programmable A to I Replacement (REPAIR) and xABE (adenosine base editor) for adenosine deamination, RNA Editing for Specific C-to-U Exchange (RESCUE) and xCBE (cytidine base editor) for cytidine deamination and dm6ACRISPR, as well as the targeted RNA methylation (TRM) and photoactivatable RNA m6A editing system using CRISPR-dCas13 (PAMEC) for m6A editing. We further highlight the emerging applications of these useful toolkits in cell biology, disease and imaging. Finally, we discuss the potential limitations, such as off-target editing, low editing efficiency and limitation for AAV delivery, and provide possible optimization strategies.

Programmable mammalian translational modulators by CRISPR-associated proteins

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

Small-molecule-based regulation of RNA-delivered circuits in mammalian cells

Programmable Transcriptional Modulation with a Structured RNA-Mediated CRISPR-dCas9 Complex

Engineering Translational Activators with CRISPR-Cas System.

Orthogonal inducible control of Cas13 circuits enables programmable RNA regulation in mammalian cells

Establishing Artificial Gene Connections Through RNA Displacement–assembly-Controlled CRISPR/Cas9 Function

Synthetic circular RNA switches and circuits that control protein expression in mammalian cells

A synthetic transcription platform for programmable gene expression in mammalian cells

Enhancement of protein translation by CRISPR/dCasRx coupled with SINEB2 repeat of noncoding RNAs

Conditional guide RNA through two intermediate hairpins for programmable CRISPR/Cas9 function: building regulatory connections between endogenous RNA expressions

Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

Progress of CRISPR‐based Programmable RNA Manipulation and Detection

Integration and Exchange of Split Dcas9 Domains for Transcriptional Controls in Mammalian Cells

An enhanced CRISPR repressor for targeted mammalian gene regulation

Intelligent guide RNA: dual toehold switches for modulating luciferase in the presence of trigger RNA

Progress of CRISPR-based programmable RNA manipulation and detection.

Orthogonal Protein-Responsive mRNA Switches for Mammalian Synthetic Biology

CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes

Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos